about
MicroRNAs as Biomarkers for Diagnosis, Prognosis and Theranostics in Prostate CancerIntegrating genetics and epigenetics in breast cancer: biological insights, experimental, computational methods and therapeutic potentialMicroRNAs: New Biomarkers for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Breast CancerFunctional heterogeneity of left inferior frontal cortex as revealed by fMRIMachine learning on brain MRI data for differential diagnosis of Parkinson's disease and Progressive Supranuclear Palsy.Frontiers for the Early Diagnosis of AD by Means of MRI Brain Imaging and Support Vector Machines.Biomarkers of Eating Disorders Using Support Vector Machine Analysis of Structural Neuroimaging Data: Preliminary ResultsTCGAbiolinks: an R/Bioconductor package for integrative analysis of TCGA dataSpidermiR: An R/Bioconductor Package for Integrative Analysis with miRNA DataLatent classes of emotional and behavioural problems in epidemiological and referred samples and their relations to DSM-IV diagnosesIntegration of mRNA expression profile, copy number alterations, and microRNA expression levels in breast cancer to improve grade definition.Computerized neuropsychological assessment in aging: testing efficacy and clinical ecology of different interfaces.Shared cortical anatomy for motor awareness and motor control.Validation of an optimized SPM procedure for FDG-PET in dementia diagnosis in a clinical settingMonte Carlo simulations in SPET and PET.An Adaptive Thresholding Method for BTV Estimation Incorporating PET Reconstruction Parameters: A Multicenter Study of the Robustness and the ReliabilityIntegration of (18)FDG-PET Metabolic and Functional Connectomes in the Early Diagnosis and Prognosis of the Alzheimer's Disease.Magnetic resonance imaging biomarkers for the early diagnosis of Alzheimer's disease: a machine learning approach.How interacting pathways are regulated by miRNAs in breast cancer subtypes.The Compression Flow as a Measure to Estimate the Brain Connectivity Changes in Resting State fMRI and 18FDG-PET Alzheimer's Disease Connectomes.MicroRNA-567 dysregulation contributes to carcinogenesis of breast cancer, targeting tumor cell proliferation, and migration.Combined analysis of chromosomal instabilities and gene expression for colon cancer progression inference.Optimizing Neuropsychological Assessments for Cognitive, Behavioral, and Functional Impairment Classification: A Machine Learning StudyFunctional correlates of preserved naming performance in amnestic Mild Cognitive Impairment.Statistical Voxel-Based Methods and [18F]FDG PET Brain Imaging: Frontiers for the Diagnosis of AD.[(18)F]FDG PET/CT features for the molecular characterization of primary breast tumors.The potential of miRNAs for diagnosis, treatment and monitoring of breast cancer.Biomarkers from in vivo molecular imaging of breast cancer: pretreatment 18F-FDG PET predicts patient prognosis, and pretreatment DWI-MR predicts response to neoadjuvant chemotherapy.Pathway-based expression profile for breast cancer diagnoses.A partial volume effect correction tailored for 18F-FDG-PET oncological studies.Integrative Analysis with Monte Carlo Cross-Validation Reveals miRNAs Regulating Pathways Cross-Talk in Aggressive Breast Cancer.A Method for Manufacturing Oncological Phantoms for the Quantification of 18F-FDG PET and DW-MRI Studies.Combination of gene expression and genome copy number alteration has a prognostic value for breast cancer.Editorial: Statistical Signal Processing in the Analysis, Characterization and Detection of Alzheimer's Disease.Partial volume corrected 18F-FDG PET mean standardized uptake value correlates with prognostic factors in breast cancer.Use of Machine Learning to Identify Children with Autism and Their Motor Abnormalities.Grid-distributed statistical parametric mapping of SPECT and PET neuroimages.Machine-Learning neuroimaging challenge for automated diagnosis of mild cognitive impairment: Lessons learnt.Integration of multiple networks and pathways identifies cancer driver genes in pan-cancer analysis.Quantitative measurement of 18F-FDG PET/CT uptake reflects the expansion of circulating plasmablasts in IgG4-related disease.
P50
Q26751983-F921163C-941D-4695-B3AE-06D819328E33Q26782613-B1BFF1DD-2F52-494F-9F76-55C228C5A35EQ26801108-AC729E35-F5E8-4537-AB96-EF15C2A35737Q29651760-10AF74BA-97FF-4CC5-BEAA-E28EF89C81B9Q30703458-A75E7E5B-3320-4BD5-94AF-5A16E5E8A3C9Q31023495-33D56DD7-ABF3-4069-9A24-300A87523BD5Q31031033-CDBBD4FF-234D-4F99-8D77-5D0BC55C6B02Q31034005-FECE994E-057A-42D0-B951-ADCE169FFC8DQ31157753-7BAE8344-D6FB-4975-83F2-4F6F1D8DCC14Q33571557-900834AA-8079-426E-B887-2F3F896BFF3FQ33670486-5C37DC03-9528-4AD5-B992-118FF2C89305Q34039730-BE3BEE97-C2F8-4312-8BBE-8B0D2D6FECC8Q34434161-F166768C-9D64-4862-B0E4-105D821A6CDBQ34477727-0A6DC985-0CE8-48BC-92D7-002C20D8970CQ34694205-9211A866-609A-4A0A-8BCB-8A80505C04C5Q35674696-2D04FE91-F1C2-4070-886F-90E254A7665CQ35841313-23062251-EBD2-4EE3-AEE5-AAEA88881B41Q36012040-F131FAB1-4B78-4129-B94D-A10606B0306AQ36276533-FD58023A-11D4-4031-889F-304E50A6E5E5Q36373985-B5FE6BBC-C974-4BA3-A904-35CF87CA428FQ37590613-1B3DCFB0-B176-4F47-8424-98F97412F3C7Q37597565-E836706F-A21E-45C6-8785-F03E80DEA7A8Q37640130-F7453657-2BCE-45F1-A48F-D087458C91E1Q38417945-20B6A136-1722-471B-BA21-DE0806DE7B3CQ38633276-347EE164-A327-43E4-BE41-5F7003D0990CQ38677216-A382E21D-0FC5-4717-BB52-2396554367C8Q38902431-93CC24F5-0A0F-4158-81E1-777557E213F0Q41109140-EC36DCC7-927E-407D-94DB-9FCE7BC305ACQ41607582-93D0BED8-3600-4B8B-A6A6-931FE41DC9D6Q42255415-43153E35-D1BF-464D-AA5C-3507F89C5542Q42381466-FE27DD7F-14F1-4055-80E1-6119A9DEF9D8Q43376072-1FF65FDC-6248-4B1D-B713-F263435B6E19Q44136674-A8977294-0CB7-4942-A15C-D58D403E6E77Q44789652-0BAD77B2-1B7B-45D5-9042-972C8FC15C98Q45403064-5052BE1E-053E-42A7-99AD-D5B136774BFEQ45955078-1134A8A3-7527-43E7-8120-CF74378E7F2EQ46319524-79A2761E-2C83-4CA2-883D-A1DBB1E17478Q47172273-1778F164-C6D7-447E-A5C5-EB216F5062CAQ47204660-9ABF4D1B-0B7A-4A31-93F9-0575C990B7A1Q47699328-D1FE6F2D-02AA-458E-B3AB-F3D1BBE92BB1
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Isabella Castiglioni
@ast
Isabella Castiglioni
@en
Isabella Castiglioni
@es
Isabella Castiglioni
@nl
Isabella Castiglioni
@sl
type
label
Isabella Castiglioni
@ast
Isabella Castiglioni
@en
Isabella Castiglioni
@es
Isabella Castiglioni
@nl
Isabella Castiglioni
@sl
prefLabel
Isabella Castiglioni
@ast
Isabella Castiglioni
@en
Isabella Castiglioni
@es
Isabella Castiglioni
@nl
Isabella Castiglioni
@sl
P106
P1153
6603570829
P21
P31
P496
0000-0001-7191-5417